Abstract:Objective To investigate the susceptibility and resistance of clinical bacterial isolates from hospitals in several regions of China.Methods Thirteen general hospitals and two children's hospitals were involved in this program. Antimicrobial susceptibility testing was carried out according to a unified protocol using Kirby-Bauer method or automated Systems. Results were analyzed according to the breakpoints of CLSI 2011.Results A total of 59 287 clinical isolates were collected from January to December 2011,of which gram negative organisms and gram positive cocci accounted for 71.5%(42 415/ 59 287) and 28.5%(16 872/59 287) respectively.The average prevalence of methicillin-resistant strains in S.aureus(MRSA) and coagulase negative staphylococcus(MRCNS) was 50.6%and 74.6%respectively.The resistance rates of MR strains toβ-lactams and other antimicrobial agents were much higher than those of MS strains.However,nearly 73.3%of MRSA strains were still susceptible to trimethoprim-sulfamethoxazole,while 88.2%of MRCNS strains were susceptible to rifampin. No staphylococcal strain was found resistant to vancomycin,teicoplanin or linezolid.In Enterococcus spp.,the resistance rates of E.faecalis strains to most tested drugs(except chloramphenicol) were much lower than those of E.faecium.Some strains of both species were resistant to vancomycin.Vancomycin resistant E.faecalis and E.faecium strains were mainly VanA type based on their phenotype.As for non-meningitis S.pneumoniae strains,the prevalence of PSSP strains isolated from both adults and children were higher than those isolated in 2010,but the prevalence of PRSP strains decreased.The prevalence of ESBLs producing strains was 50.7%in E.coli and 38.5%in Klebsiella spp.(K.pneumoniae and K.oxytoca) and 13.8%in Proteus mirabilis isolates on average.ESBLs-producing Enterobacteriaceae strains were more resistant than non-ESBLs-producing strains in terms of antibiotic resistance rate.The Enterobacteriaceae strains were still highly susceptible to carbapenems. Overall less than 6.1%of these strains were resistant to carbapenems.About 60.4%and 61.4%of Acinetobacter spp.(A. baumannii accounts for 88.6%) strains were resistant to imipenem and meropenem respectively.Compared with the data of year 2010,pan-drug resistant strains in K.pneumoniae and A.baumannii decreased.Conclusions The antibiotic resistance of clinical bacterial isolates is growing in 2011.The spread of multi-drug or pan-drug resistant strains in a specific region poses a serious threat to clinical practice and implies the importance of strengthening infection control.

CHINET 2011 Surveillance of Antibiotic Resistance in A.baumannii Isolates in China

Antimicrobial Susceptibilitytesting of Non-Fermentative Bacteria in 15 Teaching Hospitals in China: a Report from SEANIR Antimicrobial Resistance Surveillance 2008

Antimicrobiai Resistance Surveillance on Hospital-and Community-acquired Pathogens in 10 Teaching Hospitals in China

Drug resistance of Acinetobacter baumannii during 2009-2011

CHINET 2009 surveillance of antibiotic resistance in A.baumannii isolates in China

CHINET 2012 surveillance of antibiotic resistance in Acinetobacter baumannii isolates in China

CHINET 2010 surveillance of antibiotic resistance in Acinetobacter baumannii in China

Mohnarin Report of 2011 : Monitoring of Bacterial Resistance in Northwest China

Drug resistance of Acinetobacter baumanniiin ICU and general wards: a comparative study

Mohnarin report of 2011:monitoring of bacterial resistance of non-ICU inpatients

Mohnarin Report of 2011: Monitoring of Bcterial Resistance Intensive Care Unit

Mohnarin Report of 2011 : Monitoring of Bacterial Resistance in Central-Southern China

Mohnarin Report of 2010 :Surveillance of Bacterial Resistance of Non-Icu Inpatients

Resistance Trends Among 1,294 Nosocomial Acinetobacter baumannii Strains from a Tertiary General Hospital in China, 2014 - 2017.

Mohnarin Report of 2010:Monitoring of Bacterial Resistance in Intensive Care Units

Mohnarin Report of 2010 :Surveillance of Bacterial Resistance of Outpatient and Emergency Patients

Mohnarin Report of 2010:Surveillance of Resistance of Pathogens from Urine Specimens

Surveillance for clinical distribution and antimicrobial resistance of Acinetobacter baummannii from 2007 to 2010

2011 CHINET Surveillance of Bacterial Resistance in China

Surveillance for Clinical Distribution and Antimicrobial Resistance of Acinetobacter Baummanii

2012 CHINET surveillance of bacterial resistance in China